In that backdrop, the judicious thing to do was to not over-commit and thats exactly what they did: didnt kill danuglipron, said its alive and may move forward. Pfizer said theyll move the pill to a mid-stage study in the second half of this year
C tc dng lm sng da, m thm nm v tng cng sc khe tng th
(5.8) Adverse Reactions/Side Effects Most common adverse reactions (incidence 5% and at a rate at least twice placebo) in pediatric patients ages 6 to 17 years, and/or adults with ADHD were anorexia, anxiety, decreased appetite, decreased weight, diarrhea, dizziness, dry mouth, irritability, insomnia, nausea, upper abdominal pain, and vomiting
DATA-DRIVEN CARE Changes in metabolic function, inflammation, organ health, and body composition unfold over time and those changes vary from person to person
10.1530/JOE-18-0374 113